Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use 2Smoking Cessation 2Smoking 2Torulopsis 1Tobacco Use Cessation 1Tobacco Smoking 1Squamous Cell Carcinoma of Head and Neck 1Smoking Reduction 1Precancerous Conditions 1Neoplasms 1Leukoplakia, Oral 1Fractures, Bone 1Cigarette Smoking 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Tobacco Products × Clear all
NCT04620915 2026-05-08

Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

University of Oregon

Phase NA Completed
300 enrolled

Smoking Reduction, Neoplasms, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡